Požymis
Fever
Body temperature elevated above the normal range.
Santrauka
- Taip pat vadinama
- Hyperthermia, Pyrexia
- Kūno sistema
- Laboratory abnormality
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Fever, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test363 genų susiję su Fever
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Fever. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| CASKcalcium/calmodulin dependent serine protein kinase | Visada | 1 ligoje |
| CR2complement C3d receptor 2 | Visada | 2 ligose |
| CYBBcytochrome b-245 beta chain | Visada | 2 ligose |
| CYBC1cytochrome b-245 chaperone 1 | Visada | 2 ligose |
| DNASE2deoxyribonuclease 2, lysosomal | Visada | 1 ligoje |
| DNM1Ldynamin 1L | Visada | 1 ligoje |
| DSTdystonin | Visada | 2 ligose |
| EDAectodysplasin A | Visada | 1 ligoje |
| EEFSECeukaryotic elongation factor, selenocysteine-tRNA specific | Visada | 1 ligoje |
| G6PDglucose-6-phosphate dehydrogenase | Visada | 1 ligoje |
| IFNGinterferon gamma | Visada | 1 ligoje |
| IL27RAinterleukin 27 receptor subunit alpha | Visada | 1 ligoje |
| IRF1interferon regulatory factor 1 | Visada | 1 ligoje |
| IRF8interferon regulatory factor 8 | Visada | 3 ligose |
| KLHL7kelch like family member 7 | Visada | 1 ligoje |
| LCKLCK proto-oncogene, Src family tyrosine kinase | Visada | 1 ligoje |
| LIFRLIF receptor subunit alpha | Visada | 1 ligoje |
| LIPAlipase A, lysosomal acid type | Visada | 2 ligose |
| LYNLYN proto-oncogene, Src family tyrosine kinase | Visada | 1 ligoje |
| MCCC1methylcrotonyl-CoA carboxylase subunit 1 | Visada | 1 ligoje |
| MCM10minichromosome maintenance 10 replication initiation factor | Visada | 1 ligoje |
| NFU1NFU1 iron-sulfur cluster scaffold | Visada | 1 ligoje |
| NHEJ1non-homologous end joining factor 1 | Visada | 1 ligoje |
| NLRC4NLR family CARD domain containing 4 | Visada | 2 ligose |
| NLRP3NLR family pyrin domain containing 3 | Visada | 5 ligose |
| NOTCH3notch receptor 3 | Visada | 1 ligoje |
| OTULINOTU deubiquitinase with linear linkage specificity | Visada | 1 ligoje |
| PIK3CGphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | Visada | 1 ligoje |
| POMPproteasome maturation protein | Visada | 1 ligoje |
| PSMB9proteasome 20S subunit beta 9 | Visada | 1 ligoje |
| PTCRApre T cell antigen receptor alpha | Visada | 1 ligoje |
| PTPRCprotein tyrosine phosphatase receptor type C | Visada | 1 ligoje |
| RAB27ARAB27A, member RAS oncogene family | Visada | 2 ligose |
| RAG1recombination activating 1 | Visada | 3 ligose |
| RNU2-2RNA, U2 small nuclear 2 | Visada | 1 ligoje |
| RPL17ribosomal protein L17 | Visada | 1 ligoje |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Visada | 1 ligoje |
| STX11syntaxin 11 | Visada | 2 ligose |
| STXBP2syntaxin binding protein 2 | Visada | 2 ligose |
| TOP2BDNA topoisomerase II beta | Visada | 1 ligoje |
Rodyti dar 323 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ACAT1acetyl-CoA acetyltransferase 1 | Labai dažnai (80–99%) | 1 ligoje |
| ALDOAaldolase, fructose-bisphosphate A | Labai dažnai (80–99%) | 1 ligoje |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Labai dažnai (80–99%) | 1 ligoje |
| BCL10BCL10 immune signaling adaptor | Labai dažnai (80–99%) | 1 ligoje |
| BCL2BCL2 apoptosis regulator | Labai dažnai (80–99%) | 1 ligoje |
| BCL6BCL6 transcription repressor | Labai dažnai (80–99%) | 1 ligoje |
| BIRC3baculoviral IAP repeat containing 3 | Labai dažnai (80–99%) | 1 ligoje |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Labai dažnai (80–99%) | 1 ligoje |
| BLNKB cell linker | Labai dažnai (80–99%) | 1 ligoje |
| BTKBruton tyrosine kinase | Labai dažnai (80–99%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Labai dažnai (80–99%) | 2 ligose |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Labai dažnai (80–99%) | 1 ligoje |
| CCR1C-C motif chemokine receptor 1 | Labai dažnai (80–99%) | 1 ligoje |
| CD4CD4 molecule | Labai dažnai (80–99%) | 1 ligoje |
| CD79ACD79a molecule | Labai dažnai (80–99%) | 1 ligoje |
| CD79BCD79b molecule | Labai dažnai (80–99%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Labai dažnai (80–99%) | 3 ligose |
| CYBAcytochrome b-245 alpha chain | Labai dažnai (80–99%) | 1 ligoje |
| DDB2damage specific DNA binding protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| DNASE1deoxyribonuclease 1 | Labai dažnai (80–99%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Labai dažnai (80–99%) | 1 ligoje |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Labai dažnai (80–99%) | 1 ligoje |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Labai dažnai (80–99%) | 1 ligoje |
| ERCC5ERCC excision repair 5, endonuclease | Labai dažnai (80–99%) | 1 ligoje |
| ETS1ETS proto-oncogene 1, transcription factor | Labai dažnai (80–99%) | 1 ligoje |
| FASFas cell surface death receptor | Labai dažnai (80–99%) | 2 ligose |
| FCGR2BFc gamma receptor IIb | Labai dažnai (80–99%) | 1 ligoje |
| FCGR3BFc gamma receptor IIIb | Labai dažnai (80–99%) | 2 ligose |
| FOXP1forkhead box P1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Labai dažnai (80–99%) | 5 ligose |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Labai dažnai (80–99%) | 8 ligose |
| IFNGR1interferon gamma receptor 1 | Labai dažnai (80–99%) | 2 ligose |
| IGHimmunoglobulin heavy locus | Labai dažnai (80–99%) | 3 ligose |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Labai dažnai (80–99%) | 1 ligoje |
| IGHMimmunoglobulin heavy constant mu | Labai dažnai (80–99%) | 1 ligoje |
| IGLL1immunoglobulin lambda like polypeptide 1 | Labai dažnai (80–99%) | 1 ligoje |
| IKZF1IKAROS family zinc finger 1 | Labai dažnai (80–99%) | 1 ligoje |
| IL10interleukin 10 | Labai dažnai (80–99%) | 3 ligose |
| IL12Ainterleukin 12A | Labai dažnai (80–99%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Labai dažnai (80–99%) | 1 ligoje |
| IL12Binterleukin 12B | Labai dažnai (80–99%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Labai dažnai (80–99%) | 1 ligoje |
| IL6interleukin 6 | Labai dažnai (80–99%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Labai dažnai (80–99%) | 2 ligose |
| IRF4interferon regulatory factor 4 | Labai dažnai (80–99%) | 1 ligoje |
| IRF5interferon regulatory factor 5 | Labai dažnai (80–99%) | 1 ligoje |
| ITGAMintegrin subunit alpha M | Labai dažnai (80–99%) | 1 ligoje |
| JAZF1JAZF zinc finger 1 | Labai dažnai (80–99%) | 1 ligoje |
| KIAA0319LKIAA0319 like | Labai dažnai (80–99%) | 1 ligoje |
| KLRC4killer cell lectin like receptor C4 | Labai dažnai (80–99%) | 1 ligoje |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Labai dažnai (80–99%) | 1 ligoje |
| LPIN1lipin 1 | Labai dažnai (80–99%) | 2 ligose |
| LPIN2lipin 2 | Labai dažnai (80–99%) | 1 ligoje |
| LRRC8Aleucine rich repeat containing 8 VRAC subunit A | Labai dažnai (80–99%) | 1 ligoje |
| MALT1MALT1 paracaspase | Labai dažnai (80–99%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Labai dažnai (80–99%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Labai dažnai (80–99%) | 2 ligose |
| MIFmacrophage migration inhibitory factor | Labai dažnai (80–99%) | 1 ligoje |
| MLXMAX dimerization protein MLX | Labai dažnai (80–99%) | 1 ligoje |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Labai dažnai (80–99%) | 2 ligose |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Labai dažnai (80–99%) | 2 ligose |
| NCF1neutrophil cytosolic factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| NCF2neutrophil cytosolic factor 2 | Labai dažnai (80–99%) | 1 ligoje |
| NCF4neutrophil cytosolic factor 4 | Labai dažnai (80–99%) | 1 ligoje |
| OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Labai dažnai (80–99%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Labai dažnai (80–99%) | 1 ligoje |
| PDCD1programmed cell death 1 | Labai dažnai (80–99%) | 1 ligoje |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Labai dažnai (80–99%) | 1 ligoje |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| PRF1perforin 1 | Labai dažnai (80–99%) | 2 ligose |
| PRTN3proteinase 3 | Labai dažnai (80–99%) | 1 ligoje |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Labai dažnai (80–99%) | 4 ligose |
| PXKPX domain containing serine/threonine kinase like | Labai dažnai (80–99%) | 1 ligoje |
| SPI1Spi-1 proto-oncogene | Labai dažnai (80–99%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Labai dažnai (80–99%) | 2 ligose |
| STAT4signal transducer and activator of transcription 4 | Labai dažnai (80–99%) | 3 ligose |
| TCF3transcription factor 3 | Labai dažnai (80–99%) | 1 ligoje |
| TLR4toll like receptor 4 | Labai dažnai (80–99%) | 1 ligoje |
| TLR7toll like receptor 7 | Labai dažnai (80–99%) | 2 ligose |
| TNFAIP3TNF alpha induced protein 3 | Labai dažnai (80–99%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Labai dažnai (80–99%) | 1 ligoje |
| TNIP1TNFAIP3 interacting protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Labai dažnai (80–99%) | 2 ligose |
| UBAC2UBA domain containing 2 | Labai dažnai (80–99%) | 1 ligoje |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Labai dažnai (80–99%) | 1 ligoje |
| UNC13Dunc-13 homolog D | Labai dažnai (80–99%) | 2 ligose |
| WASWASP actin nucleation promoting factor | Labai dažnai (80–99%) | 1 ligoje |
| XIAPX-linked inhibitor of apoptosis | Labai dažnai (80–99%) | 1 ligoje |
| XPAXPA, DNA damage recognition and repair factor | Labai dažnai (80–99%) | 1 ligoje |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Labai dažnai (80–99%) | 1 ligoje |
| ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| ADAadenosine deaminase | Dažnai (30–79%) | 1 ligoje |
| ADA2adenosine deaminase 2 | Dažnai (30–79%) | 1 ligoje |
| AK2adenylate kinase 2 | Dažnai (30–79%) | 1 ligoje |
| ALKALK receptor tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| AP1S3adaptor related protein complex 1 subunit sigma 3 | Dažnai (30–79%) | 1 ligoje |
| AQP2aquaporin 2 | Dažnai (30–79%) | 1 ligoje |
| ASXL1ASXL transcriptional regulator 1 | Dažnai (30–79%) | 1 ligoje |
| ATMATM serine/threonine kinase | Dažnai (30–79%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Dažnai (30–79%) | 1 ligoje |
| AVParginine vasopressin | Dažnai (30–79%) | 1 ligoje |
| AVPR2arginine vasopressin receptor 2 | Dažnai (30–79%) | 1 ligoje |
| BCORBCL6 corepressor | Dažnai (30–79%) | 1 ligoje |
| BCRBCR activator of RhoGEF and GTPase | Dažnai (30–79%) | 1 ligoje |
| BTNL2butyrophilin like 2 | Dažnai (30–79%) | 1 ligoje |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Dažnai (30–79%) | 2 ligose |
| CALRcalreticulin | Dažnai (30–79%) | 3 ligose |
| CCND1cyclin D1 | Dažnai (30–79%) | 1 ligoje |
| CD247CD247 molecule | Dažnai (30–79%) | 1 ligoje |
| CD27CD27 molecule | Dažnai (30–79%) | 1 ligoje |
| CD3DCD3 delta subunit of T-cell receptor complex | Dažnai (30–79%) | 1 ligoje |
| CD3ECD3 epsilon subunit of T-cell receptor complex | Dažnai (30–79%) | 1 ligoje |
| CHD7chromodomain helicase DNA binding protein 7 | Dažnai (30–79%) | 1 ligoje |
| CLPBClpB family mitochondrial disaggregase | Dažnai (30–79%) | 1 ligoje |
| COL1A1collagen type I alpha 1 chain | Dažnai (30–79%) | 2 ligose |
| CPT2carnitine palmitoyltransferase 2 | Dažnai (30–79%) | 2 ligose |
| DCLRE1CDNA cross-link repair 1C | Dažnai (30–79%) | 1 ligoje |
| ELANEelastase, neutrophil expressed | Dažnai (30–79%) | 2 ligose |
| F5coagulation factor V | Dažnai (30–79%) | 1 ligoje |
| FAHfumarylacetoacetate hydrolase | Dažnai (30–79%) | 1 ligoje |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Dažnai (30–79%) | 1 ligoje |
| GATA2GATA binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| GFI1growth factor independent 1 transcriptional repressor | Dažnai (30–79%) | 1 ligoje |
| GPR35G protein-coupled receptor 35 | Dažnai (30–79%) | 1 ligoje |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Dažnai (30–79%) | 1 ligoje |
| HAVCR2hepatitis A virus cellular receptor 2 | Dažnai (30–79%) | 2 ligose |
| IL1R1interleukin 1 receptor type 1 | Dažnai (30–79%) | 1 ligoje |
| IL2RGinterleukin 2 receptor subunit gamma | Dažnai (30–79%) | 1 ligoje |
| IL36RNinterleukin 36 receptor antagonist | Dažnai (30–79%) | 2 ligose |
| IL7Rinterleukin 7 receptor | Dažnai (30–79%) | 2 ligose |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| JAK2Janus kinase 2 | Dažnai (30–79%) | 3 ligose |
| KITKIT proto-oncogene, receptor tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| LBRlamin B receptor | Dažnai (30–79%) | 1 ligoje |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Dažnai (30–79%) | 1 ligoje |
| LMO1LIM domain only 1 | Dažnai (30–79%) | 1 ligoje |
| LYSTlysosomal trafficking regulator | Dažnai (30–79%) | 1 ligoje |
| MAP2K1mitogen-activated protein kinase kinase 1 | Dažnai (30–79%) | 1 ligoje |
| MRPS7mitochondrial ribosomal protein S7 | Dažnai (30–79%) | 1 ligoje |
| MST1macrophage stimulating 1 | Dažnai (30–79%) | 1 ligoje |
| MTHFSmethenyltetrahydrofolate synthetase | Dažnai (30–79%) | 1 ligoje |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Dažnai (30–79%) | 1 ligoje |
| NABP1nucleic acid binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| NDUFA2NADH:ubiquinone oxidoreductase subunit A2 | Dažnai (30–79%) | 1 ligoje |
| NOD2nucleotide binding oligomerization domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| NPM1nucleophosmin 1 | Dažnai (30–79%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Dažnai (30–79%) | 1 ligoje |
| NUDCD3NudC domain containing 3 | Dažnai (30–79%) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Dažnai (30–79%) | 1 ligoje |
| PHOX2Bpaired like homeobox 2B | Dažnai (30–79%) | 1 ligoje |
| PMLPML nuclear body scaffold | Dažnai (30–79%) | 1 ligoje |
| POLR3ARNA polymerase III subunit A | Dažnai (30–79%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Dažnai (30–79%) | 2 ligose |
| PSMB10proteasome 20S subunit beta 10 | Dažnai (30–79%) | 1 ligoje |
| RAG2recombination activating 2 | Dažnai (30–79%) | 2 ligose |
| RANBP2RAN binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| RARAretinoic acid receptor alpha | Dažnai (30–79%) | 1 ligoje |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Dažnai (30–79%) | 1 ligoje |
| RUNX1RUNX family transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| RYR1ryanodine receptor 1 | Dažnai (30–79%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Dažnai (30–79%) | 1 ligoje |
| SCYL1SCY1 like pseudokinase 1 | Dažnai (30–79%) | 1 ligoje |
| SEMA4Dsemaphorin 4D | Dažnai (30–79%) | 1 ligoje |
| SLC29A3solute carrier family 29 member 3 | Dažnai (30–79%) | 1 ligoje |
| SRP19signal recognition particle 19 | Dažnai (30–79%) | 1 ligoje |
| SRSF2serine and arginine rich splicing factor 2 | Dažnai (30–79%) | 1 ligoje |
| STAT1signal transducer and activator of transcription 1 | Dažnai (30–79%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Dažnai (30–79%) | 2 ligose |
| STAT5Bsignal transducer and activator of transcription 5B | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Dažnai (30–79%) | 1 ligoje |
| TCF4transcription factor 4 | Dažnai (30–79%) | 1 ligoje |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Dažnai (30–79%) | 1 ligoje |
| TET2tet methylcytosine dioxygenase 2 | Dažnai (30–79%) | 2 ligose |
| TICAM1TIR domain containing adaptor molecule 1 | Dažnai (30–79%) | 1 ligoje |
| TLR3toll like receptor 3 | Dažnai (30–79%) | 1 ligoje |
| TRAF3TNF receptor associated factor 3 | Dažnai (30–79%) | 1 ligoje |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Dažnai (30–79%) | 1 ligoje |
| UNC93B1unc-93B1 regulator of TLR signaling | Dažnai (30–79%) | 1 ligoje |
| UQCRHubiquinol-cytochrome c reductase hinge protein | Dažnai (30–79%) | 1 ligoje |
| ZBTB16zinc finger and BTB domain containing 16 | Dažnai (30–79%) | 1 ligoje |
| ABCC2ATP binding cassette subfamily C member 2 | Kartais (5–29%) | 1 ligoje |
| ABCC6ATP binding cassette subfamily C member 6 | Kartais (5–29%) | 1 ligoje |
| ACTN4actinin alpha 4 | Kartais (5–29%) | 1 ligoje |
| ANK1ankyrin 1 | Kartais (5–29%) | 1 ligoje |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Kartais (5–29%) | 1 ligoje |
| ANKHANKH inorganic pyrophosphate transport regulator | Kartais (5–29%) | 1 ligoje |
| ANLNanillin, actin binding protein | Kartais (5–29%) | 1 ligoje |
| APOL1apolipoprotein L1 | Kartais (5–29%) | 1 ligoje |
| ARHGAP24Rho GTPase activating protein 24 | Kartais (5–29%) | 1 ligoje |
| ARHGDIARho GDP dissociation inhibitor alpha | Kartais (5–29%) | 1 ligoje |
| ATP13A2ATPase cation transporting 13A2 | Kartais (5–29%) | 1 ligoje |
| AVILadvillin | Kartais (5–29%) | 1 ligoje |
| BRCA1BRCA1 DNA repair associated | Kartais (5–29%) | 1 ligoje |
| BRCA2BRCA2 DNA repair associated | Kartais (5–29%) | 2 ligose |
| CD2APCD2 associated protein | Kartais (5–29%) | 1 ligoje |
| CFTRCF transmembrane conductance regulator | Kartais (5–29%) | 2 ligose |
| COL4A3collagen type IV alpha 3 chain | Kartais (5–29%) | 1 ligoje |
| COQ8Bcoenzyme Q8B | Kartais (5–29%) | 1 ligoje |
| CRB2crumbs cell polarity complex component 2 | Kartais (5–29%) | 1 ligoje |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Kartais (5–29%) | 1 ligoje |
| DAAM2dishevelled associated activator of morphogenesis 2 | Kartais (5–29%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Kartais (5–29%) | 1 ligoje |
| EIF2AK3eukaryotic translation initiation factor 2 alpha kinase 3 | Kartais (5–29%) | 1 ligoje |
| EMP2epithelial membrane protein 2 | Kartais (5–29%) | 1 ligoje |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Kartais (5–29%) | 1 ligoje |
| EPB42erythrocyte membrane protein band 4.2 | Kartais (5–29%) | 1 ligoje |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Kartais (5–29%) | 1 ligoje |
| GLAgalactosidase alpha | Kartais (5–29%) | 1 ligoje |
| GPC3glypican 3 | Kartais (5–29%) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Kartais (5–29%) | 1 ligoje |
| HMBShydroxymethylbilane synthase | Kartais (5–29%) | 1 ligoje |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Kartais (5–29%) | 2 ligose |
| IFIH1interferon induced with helicase C domain 1 | Kartais (5–29%) | 1 ligoje |
| INF2inverted formin 2 | Kartais (5–29%) | 1 ligoje |
| IRAK4interleukin 1 receptor associated kinase 4 | Kartais (5–29%) | 1 ligoje |
| KANK2KN motif and ankyrin repeat domains 2 | Kartais (5–29%) | 1 ligoje |
| LAMA5laminin subunit alpha 5 | Kartais (5–29%) | 1 ligoje |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Kartais (5–29%) | 1 ligoje |
| MPLMPL proto-oncogene, thrombopoietin receptor | Kartais (5–29%) | 2 ligose |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Kartais (5–29%) | 1 ligoje |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Kartais (5–29%) | 1 ligoje |
| MT-CYBmitochondrially encoded cytochrome b | Kartais (5–29%) | 1 ligoje |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Kartais (5–29%) | 2 ligose |
| MT-ND2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 | Kartais (5–29%) | 1 ligoje |
| MT-ND3mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 | Kartais (5–29%) | 1 ligoje |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Kartais (5–29%) | 2 ligose |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Kartais (5–29%) | 2 ligose |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Kartais (5–29%) | 2 ligose |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Kartais (5–29%) | 1 ligoje |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Kartais (5–29%) | 1 ligoje |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Kartais (5–29%) | 1 ligoje |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Kartais (5–29%) | 2 ligose |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Kartais (5–29%) | 1 ligoje |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Kartais (5–29%) | 1 ligoje |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Kartais (5–29%) | 1 ligoje |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Kartais (5–29%) | 1 ligoje |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Kartais (5–29%) | 2 ligose |
| MYD88MYD88 innate immune signal transduction adaptor | Kartais (5–29%) | 2 ligose |
| MYO1Emyosin IE | Kartais (5–29%) | 1 ligoje |
| NPHS1NPHS1 adhesion molecule, nephrin | Kartais (5–29%) | 1 ligoje |
| NPHS2NPHS2 stomatin family member, podocin | Kartais (5–29%) | 1 ligoje |
| NUP107nucleoporin 107 | Kartais (5–29%) | 1 ligoje |
| NUP133nucleoporin 133 | Kartais (5–29%) | 1 ligoje |
| NUP160nucleoporin 160 | Kartais (5–29%) | 1 ligoje |
| NUP205nucleoporin 205 | Kartais (5–29%) | 1 ligoje |
| NUP37nucleoporin 37 | Kartais (5–29%) | 1 ligoje |
| NUP85nucleoporin 85 | Kartais (5–29%) | 1 ligoje |
| NUP93nucleoporin 93 | Kartais (5–29%) | 1 ligoje |
| PAX2paired box 2 | Kartais (5–29%) | 1 ligoje |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Kartais (5–29%) | 1 ligoje |
| PLCE1phospholipase C epsilon 1 | Kartais (5–29%) | 1 ligoje |
| PMM2phosphomannomutase 2 | Kartais (5–29%) | 1 ligoje |
| POU6F2POU class 6 homeobox 2 | Kartais (5–29%) | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Kartais (5–29%) | 2 ligose |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Kartais (5–29%) | 1 ligoje |
| PTPROprotein tyrosine phosphatase receptor type O | Kartais (5–29%) | 1 ligoje |
| RESTRE1 silencing transcription factor | Kartais (5–29%) | 1 ligoje |
| RNU5B-1RNA, U5B small nuclear 1 | Kartais (5–29%) | 1 ligoje |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| SCNN1Asodium channel epithelial 1 subunit alpha | Kartais (5–29%) | 1 ligoje |
| SCNN1Bsodium channel epithelial 1 subunit beta | Kartais (5–29%) | 1 ligoje |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Kartais (5–29%) | 1 ligoje |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Kartais (5–29%) | 1 ligoje |
| SPTA1spectrin alpha, erythrocytic 1 | Kartais (5–29%) | 2 ligose |
| SPTBspectrin beta, erythrocytic | Kartais (5–29%) | 2 ligose |
| SPTBN1spectrin beta, non-erythrocytic 1 | Kartais (5–29%) | 1 ligoje |
| TBC1D8BTBC1 domain family member 8B | Kartais (5–29%) | 1 ligoje |
| THtyrosine hydroxylase | Kartais (5–29%) | 1 ligoje |
| TNFRSF11BTNF receptor superfamily member 11b | Kartais (5–29%) | 1 ligoje |
| TRIM28tripartite motif containing 28 | Kartais (5–29%) | 1 ligoje |
| TRIP13thyroid hormone receptor interactor 13 | Kartais (5–29%) | 1 ligoje |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Kartais (5–29%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Kartais (5–29%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Kartais (5–29%) | 1 ligoje |
| TSPOAP1TSPO associated protein 1 | Kartais (5–29%) | 1 ligoje |
| WT1WT1 transcription factor | Kartais (5–29%) | 2 ligose |
| ZFYVE19zinc finger FYVE-type containing 19 | Kartais (5–29%) | 1 ligoje |
| ZNF699zinc finger protein 699 | Kartais (5–29%) | 1 ligoje |
| CD28CD28 molecule | Retai (1–4 %) | 1 ligoje |
| CHEK2checkpoint kinase 2 | Retai (1–4 %) | 1 ligoje |
| EPB41erythrocyte membrane protein band 4.1 | Retai (1–4 %) | 1 ligoje |
| GYPCglycophorin C (Gerbich blood group) | Retai (1–4 %) | 1 ligoje |
| NAB2NGFI-A binding protein 2 | Retai (1–4 %) | 1 ligoje |
| RB1RB transcriptional corepressor 1 | Retai (1–4 %) | 1 ligoje |
| SLC34A2solute carrier family 34 member 2 | Retai (1–4 %) | 1 ligoje |
| SLC5A1solute carrier family 5 member 1 | Retai (1–4 %) | 1 ligoje |
| STAT6signal transducer and activator of transcription 6 | Retai (1–4 %) | 1 ligoje |
| TNFRSF1BTNF receptor superfamily member 1B | Retai (1–4 %) | 1 ligoje |
| TP53tumor protein p53 | Retai (1–4 %) | 1 ligoje |
| UBR5ubiquitin protein ligase E3 component n-recognin 5 | Retai (1–4 %) | 1 ligoje |
| ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif 13 | Neužfiksuota | 1 ligoje |
| ALPLalkaline phosphatase, biomineralization associated | Neužfiksuota | 1 ligoje |
| BACH2BACH transcriptional regulator 2 | Neužfiksuota | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Neužfiksuota | 1 ligoje |
| CD244CD244 molecule | Neužfiksuota | 1 ligoje |
| CFHcomplement factor H | Neužfiksuota | 1 ligoje |
| CFHR1complement factor H related 1 | Neužfiksuota | 1 ligoje |
| CFHR3complement factor H related 3 | Neužfiksuota | 1 ligoje |
| CIITAclass II major histocompatibility complex transactivator | Neužfiksuota | 1 ligoje |
| CPOXcoproporphyrinogen oxidase | Neužfiksuota | 1 ligoje |
| CTRCchymotrypsin C | Neužfiksuota | 1 ligoje |
| CYP21A2cytochrome P450 family 21 subfamily A member 2 | Neužfiksuota | 1 ligoje |
| EIF2B1eukaryotic translation initiation factor 2B subunit alpha | Neužfiksuota | 1 ligoje |
| FBP1fructose-bisphosphatase 1 | Neužfiksuota | 1 ligoje |
| GAAalpha glucosidase | Neužfiksuota | 1 ligoje |
| HTR1A5-hydroxytryptamine receptor 1A | Neužfiksuota | 1 ligoje |
| KCNJ1potassium inwardly rectifying channel subfamily J member 1 | Neužfiksuota | 1 ligoje |
| KIF1Bkinesin family member 1B | Neužfiksuota | 1 ligoje |
| KRT18keratin 18 | Neužfiksuota | 1 ligoje |
| NFKBIL1NFKB inhibitor like 1 | Neužfiksuota | 1 ligoje |
| NGLY1N-glycanase 1 | Neužfiksuota | 1 ligoje |
| PRSS1serine protease 1 | Neužfiksuota | 1 ligoje |
| PRSS2serine protease 2 | Neužfiksuota | 1 ligoje |
| SH2B3SH2B adaptor protein 3 | Neužfiksuota | 1 ligoje |
| SLC12A1solute carrier family 12 member 1 | Neužfiksuota | 1 ligoje |
| SLC19A3solute carrier family 19 member 3 | Neužfiksuota | 1 ligoje |
| SLC22A4solute carrier family 22 member 4 | Neužfiksuota | 1 ligoje |
| SPINK1serine peptidase inhibitor Kazal type 1 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites